glp 1 drugs brands GLP-1s Exclusive | GLP-1 Friendly Frozen
Description
In addition to changing blood sugar control, the medications can curb hunger levels
In the future, biomarker-guided precision treatment approaches should be establishedfor example, using dynamic NT-proBNP monitoring combined with myocardial strain echocardiography to identify subgroups more likely to respond favorably to GLP-1RAs therapy
Lancet 406 , 149162 (2025)
Exenatide is anticipated to register 35.4% of the market share in 2024
Tirzepatide (Mounjaro for diabetes
Makino et al
